Leucine - Rich Repeat Kinase (LRRK) - 2 Inhibitors - Pipeline Insights, 2015 Covers Pre-Registration Phase, Clinical Phases (Phase III, Phase II & Phase I)
DelveInsight's, Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.
View full press release